These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3958353

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP, Reid PR, Platia EV, Griffith LS.
    Am J Cardiol; 1985 Feb 01; 55(4):375-9. PubMed ID: 3969872
    [Abstract] [Full Text] [Related]

  • 43. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ.
    Heart; 1998 Apr 01; 79(4):331-6. PubMed ID: 9616338
    [Abstract] [Full Text] [Related]

  • 44. Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity.
    Kerin NZ, Blevins RD, Benaderet D, Faitel K, Jarandilla R, Garfinkel C, Klein S, Rubenfire M.
    Am J Cardiol; 1986 Jan 01; 57(1):128-30. PubMed ID: 3942055
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Prospective comparison of Holter monitoring and electrophysiologic study in patients with coronary artery disease and sustained ventricular tachyarrhythmias.
    Swerdlow CD, Peterson J.
    Am J Cardiol; 1985 Oct 01; 56(10):577-80. PubMed ID: 4050691
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of mexiletine in patients with ventricular tachycardia.
    Kim SG, Seiden SW, Matos JA, Waspe LE, Fisher JD.
    Am Heart J; 1986 Jul 01; 112(1):14-9. PubMed ID: 3728269
    [Abstract] [Full Text] [Related]

  • 51. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.
    Nademanee K, Singh BN, Hendrickson JA, Reed AW, Melmed S, Hershman J.
    Circulation; 1982 Jul 01; 66(1):202-11. PubMed ID: 7083508
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillation.
    Schützenberger W, Leisch F, Kerschner K, Harringer W, Herbinger W.
    Br Heart J; 1989 Nov 01; 62(5):367-71. PubMed ID: 2590589
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A, Massacci C, Curzi G, Pigini G, Costantini C, Bilancini A, Blandini A.
    G Ital Cardiol; 1986 May 01; 16(5):417-26. PubMed ID: 3732727
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.